Highlights
1 patent
About
Morphology Ultrasonic Sperm Enrichment
XyAid develops a method of ultrasonic separation between normal andabnormal spermatozoa. The separation process isbased on differentmorphological structures andconcentrations of the normal and abnormal spermatozoa. The UV treatmentsubstantially enriches the fraction of normal cells, which increases fertility and assists with cell reproduction. XyAid's technology is named Assisted Reproduction Technologies and is relevant for intrauterine insemination, in-vitro fertilization, and intro cytoplasmic sperm injection.
Identity
| Name | xyAid |
|---|---|
| Slug | xyaid |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwMOp0bYKDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Jan 2018 |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Jerusalem, Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Simulation & ImagingUltrasound
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
stealthmodeultrasoundfertilitymedical-devices
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}